Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL)
Recent success of novel therapies has improved treatment of chronic lymphocytic leukemia (CLL) patients, but most of them still require several treatment regimes. To improve treatment choice, prognostic markers suitable for prediction of disease outcome are required. Several molecular/genetic marker...
Guardado en:
Autores principales: | Kübra Kaban, Sarah M. Greiner, Samuel Holzmayer, Claudia Tandler, Sophie Meyer, Clemens Hinterleitner, Helmut R. Salih, Melanie Märklin, Jonas S. Heitmann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/48045c6f277e48eea4ecfe0855fc7d48 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
BTLA Expression in CLL: Epigenetic Regulation and Impact on CLL B Cell Proliferation and Ability to IL-4 Production
por: Lidia Karabon, et al.
Publicado: (2021) -
EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8+ T Cells
por: Christopher J. Stairiker, et al.
Publicado: (2021) -
The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy
por: Ujjani C, et al.
Publicado: (2020) -
Soil properties influencing phytoparasitic nematode population on Chilean vineyards
por: Fajardo P,Mario, et al.
Publicado: (2011) -
Model Development and Transient Analysis of the HCPB BB BOP DEMO Configuration Using the Apros System Code
por: Marton Szogradi, et al.
Publicado: (2021)